Skip to content

Corneal Transplant Follow-up Study - impact of tissue matching

Evaluation of HLA class II histocompatibility matching and cytokine polymorphisms in corneal transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN25094892
Enrollment
1200
Registered
2008-10-06
Start date
1998-09-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal transplantation Injury, Occupational Diseases, Poisoning Failure and rejection of transplanted organs and tissues

Interventions

Patients receive a corneal transplant from a donor matched for HLA class I antigens (not more than two HLA-A and/or HLA-B mismatches combined) with 0, 1 or 2 HLA class II (HLA-DR) mismatches. The leve

Sponsors

University of Bristol (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients of any age or sex tissue typed by polymerase chain reaction using sequence-specific primers (PCR-SSP) or PCR using sequence-specific oligonucleotides (PCR-SSO) with corneal disease requiring a corneal transplant and with the following conditions that increase the risk of cell-mediated rejection: 1. Previously failed corneal transplant 2. Vascularised cornea 3. Ocular inflammatory disease 4. Bullous keratopathy consequent to previous ocular surgery

Exclusion criteria

Exclusion criteria: Patients requiring corneal transplants where the risk of rejection is low (e.g., keratoconus and Fuchs' endothelial dystrophy) and where there are no known pre-operative risk factors for rejection.

Design outcomes

Primary

MeasureTime frame
Time to first rejection

Secondary

MeasureTime frame
Time to graft failure

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 18, 2026